Article may be outdated

This article is 10 days old. Some details may have changed since publication.

The Conversation Africa·3 min read·medium

First mRNA flu shot approved by FDA bodes well for improving drugs of the future – though a few hurdles remain before mRNA can move beyond vaccines - The Conversation

L
Li Li
First mRNA flu shot approved by FDA bodes well for improving drugs of the future – though a few hurdles remain before mRNA can move beyond vaccines - The Conversation
AI Summary

The FDA's approval of the first mRNA flu vaccine marks a significant milestone in medical technology. While successful, researchers note that applying mRNA platforms to diseases beyond vaccines remains a complex challenge.

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic proces…

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealth

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in